512 related items for PubMed ID: 10804944
1. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy.
Kauli R, Zaizov R, Lazar L, Pertzelan A, Laron Z, Galatzer A, Phillip M, Yaniv Y, Cohen IJ.
Isr Med Assoc J; 2000 Feb; 2(2):158-63. PubMed ID: 10804944
[Abstract] [Full Text] [Related]
2. Children with type I Gaucher disease: growing into adulthood with and without enzyme therapy.
Zimran A, Abrahamov A, Elstein D.
Isr Med Assoc J; 2000 Feb; 2(2):80-1. PubMed ID: 10804921
[No Abstract] [Full Text] [Related]
3. Is complete catch-up possible for stunted malnourished children?
Golden MH.
Eur J Clin Nutr; 1994 Feb; 48 Suppl 1():S58-70; discussion S71. PubMed ID: 8005092
[Abstract] [Full Text] [Related]
4. Growth and sexual maturation in children with thalassemia major.
Yesilipek MA, Bircan I, Oygür N, Ertug H, Yegin O, Güven AG.
Haematologica; 1993 Feb; 78(1):30-3. PubMed ID: 8491419
[Abstract] [Full Text] [Related]
5. Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy.
Zevin S, Abrahamov A, Hadas-Halpern I, Kannai R, Levy-Lahad E, Horowitz M, Zimran A.
Q J Med; 1993 Sep; 86(9):565-73. PubMed ID: 8255971
[Abstract] [Full Text] [Related]
6. [Natural history of intrauterine growth retardation: pubertal growth and adult height].
Job JC, Rolland A.
Arch Fr Pediatr; 1986 May; 43(5):301-6. PubMed ID: 3778088
[Abstract] [Full Text] [Related]
7. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
Lagrou K, Xhrouet-Heinrichs D, Massa G, Vandeweghe M, Bourguignon JP, De Schepper J, de Zegher F, Ernould C, Heinrichs C, Malvaux P, Craen M.
J Pediatr Endocrinol Metab; 2001 May; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
[Abstract] [Full Text] [Related]
8. Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment.
Erikson A.
Acta Paediatr Scand Suppl; 1986 May; 326():1-42. PubMed ID: 3296644
[Abstract] [Full Text] [Related]
9. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.
Piran S, Roberts A, Patterson MA, Amato D.
Blood Cells Mol Dis; 2009 May; 43(3):289-93. PubMed ID: 19793665
[Abstract] [Full Text] [Related]
10. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
Charrow J, Dulisse B, Grabowski GA, Weinreb NJ.
Clin Genet; 2007 Mar; 71(3):205-11. PubMed ID: 17309642
[Abstract] [Full Text] [Related]
11. [French results of enzyme replacement therapy in Gaucher's disease].
Schaison G, Caubel I, Belmatoug N, Billette de Villemeur T, Saudubray JM.
Bull Acad Natl Med; 2002 Mar; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
[Abstract] [Full Text] [Related]
12. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF, McNeill E, Young D, Donaldson MD.
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[Abstract] [Full Text] [Related]
13. Growth and final height after liver transplantation during childhood.
Scheenstra R, Gerver WJ, Odink RJ, van Soest H, Peeters PM, Verkade HJ, Sauer PJ.
J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):165-71. PubMed ID: 18664868
[Abstract] [Full Text] [Related]
14. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
Tóth J, Szücs FZ, Benkö K, Maródi L.
Orv Hetil; 2003 Apr 20; 144(16):749-55. PubMed ID: 12778625
[Abstract] [Full Text] [Related]
15. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
Trollmann R, Bakker B, Lundberg M, Doerr HG.
Pediatr Rehabil; 2006 Apr 20; 9(2):144-8. PubMed ID: 16449073
[Abstract] [Full Text] [Related]
16. Effect of asthma on growth and puberty.
Balfour-Lynn L.
Pediatrician; 1987 Apr 20; 14(4):237-41. PubMed ID: 3331205
[Abstract] [Full Text] [Related]
17. Delayed puberty in chronic illness.
Pozo J, Argente J.
Best Pract Res Clin Endocrinol Metab; 2002 Mar 20; 16(1):73-90. PubMed ID: 11987900
[Abstract] [Full Text] [Related]
18. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
Duan YL, Zhang YH, Zang Y, Shi HP, Zhang WM, Hu YM.
Zhonghua Er Ke Za Zhi; 2006 Sep 20; 44(9):653-6. PubMed ID: 17217655
[Abstract] [Full Text] [Related]
19. Earlier initiation of GH therapy does not influence adult height but enables earlier start of pubertal induction in children with multiple pituitary hormone deficiency.
Kawai M, Momoi T, Mamada M, Yorifuji T, Nakahata T.
Clin Endocrinol (Oxf); 2004 May 20; 60(5):608-12. PubMed ID: 15104564
[Abstract] [Full Text] [Related]
20. Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease.
Altarescu G, Schiffmann R, Parker CC, Moore DF, Kreps C, Brady RO, Barton NW.
Blood Cells Mol Dis; 2000 Aug 20; 26(4):285-90. PubMed ID: 11042029
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
